Skip to main content
. Author manuscript; available in PMC: 2013 Oct 7.
Published in final edited form as: Eur J Nucl Med Mol Imaging. 2011 Dec 8;39(3):544–547. doi: 10.1007/s00259-011-2005-8

Table 1.

Comparison between the effective dose extrapolated from monkeys for nine different tracers and the actual effective dose measured in humans

Tracer Dose from monkeys
(µSv/MBq)
Reference Dose from humans
(µSv/MBq)
Reference % difference as compared
to monkey estimatesa
% difference as compared
to the human meanb
11C-BTA-1 7.4 Parsey et al. (2005) [7] 4.3 Thees et al. (2007) [8] −72.1 −25.1
11C-(R)-Rolipram 6.6 Sprague et al. (2008) [2] 4.8 Sprague et al. (2008) [2] −37.5 −16.4
11C-DASB 6.2 Tipre et al. (2004) [9] 7.0 Lu et al. (2004) [10] 11.4 21.9
11C-PBR28 10.3 Brown et al. (2007) [3] 6.6 Brown et al. (2007) [3] −56.1 14.9
11C-CUMI-101 6.9 Parsey (unpubl.) 5.3 Hines et al. (2011) [11] −30.2 −7.7
11C-MePPEP 6.6 NIMH/SNIDD [12] 4.6 Terry et al. (2010) [13] −43.5 −19.9
11C-dLop 9.4 Liow et al. (2009) [14] 7.8 Seneca et al. (2009) [15] −20.5 35.8
11C-(R)-PK11195 5.3 Our unpubl. data 5.0 Hirvonen et al. (2010) [16] −6.0 −13.0
4.6 Kumar et al. (2010) [17] −13 −19.9
11C-raclopride 6.7 Herscovitch et al. (1997) [18] 6.3 Slifstein et al. (2006) [19] −6.3 9.7
6.7 Ribeiro et al. (2005) [20] 0 16.6
Mean±SD 7.3±1.6 5.7±1.2 −29.0±26.5 0±21.7
a

Obtained for each tracer j by: (human dosej − monkey dosej)*100/human dosej

b

Obtained for each tracer j by: (human dosej − mean human dose)*100/mean human dose